BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 31222138)

  • 1. Deep-learning-based imaging-classification identified cingulate island sign in dementia with Lewy bodies.
    Iizuka T; Fukasawa M; Kameyama M
    Sci Rep; 2019 Jun; 9(1):8944. PubMed ID: 31222138
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cingulate island sign on FDG-PET is associated with medial temporal lobe atrophy in dementia with Lewy bodies.
    Iizuka T; Kameyama M
    Ann Nucl Med; 2016 Jul; 30(6):421-9. PubMed ID: 27098829
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Spatial metabolic profiles to discriminate dementia with Lewy bodies from Alzheimer disease.
    Iizuka T; Kameyama M
    J Neurol; 2020 Jul; 267(7):1960-1969. PubMed ID: 32170446
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differentiating Alzheimer's Disease from Dementia with Lewy Bodies Using a Deep Learning Technique Based on Structural Brain Connectivity.
    Wada A; Tsuruta K; Irie R; Kamagata K; Maekawa T; Fujita S; Koshino S; Kumamaru K; Suzuki M; Nakanishi A; Hori M; Aoki S
    Magn Reson Med Sci; 2019 Jul; 18(3):219-224. PubMed ID: 30504639
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Validation of the cingulate island sign with optimized ratios for discriminating dementia with Lewy bodies from Alzheimer's disease using brain perfusion SPECT.
    Imabayashi E; Soma T; Sone D; Tsukamoto T; Kimura Y; Sato N; Murata M; Matsuda H
    Ann Nucl Med; 2017 Aug; 31(7):536-543. PubMed ID: 28547521
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Cingulate Island Sign on FDG-PET vs. IMP-SPECT to Assess Mild Cognitive Impairment in Alzheimer's Disease vs. Dementia with Lewy Bodies.
    Chiba Y; Fujishiro H; Iseki E; Kasanuki K; Sato K
    J Neuroimaging; 2019 Nov; 29(6):712-720. PubMed ID: 31199036
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differentiating Dementia with Lewy Bodies and Alzheimer's Disease by Deep Learning to Structural MRI.
    Nemoto K; Sakaguchi H; Kasai W; Hotta M; Kamei R; Noguchi T; Minamimoto R; Arai T; Asada T
    J Neuroimaging; 2021 May; 31(3):579-587. PubMed ID: 33476487
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Cingulate Island Sign].
    Imabayashi E
    Brain Nerve; 2018 Aug; 70(8):879-888. PubMed ID: 30082498
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cingulate island sign temporally changes in dementia with Lewy bodies.
    Iizuka T; Iizuka R; Kameyama M
    Sci Rep; 2017 Nov; 7(1):14745. PubMed ID: 29116145
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regional cortical perfusion on arterial spin labeling MRI in dementia with Lewy bodies: Associations with clinical severity, glucose metabolism and tau PET.
    Nedelska Z; Senjem ML; Przybelski SA; Lesnick TG; Lowe VJ; Boeve BF; Arani A; Vemuri P; Graff-Radford J; Ferman TJ; Jones DT; Savica R; Knopman DS; Petersen RC; Jack CR; Kantarci K
    Neuroimage Clin; 2018; 19():939-947. PubMed ID: 30003031
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A visual rating scale for cingulate island sign on 18F-FDG-PET to differentiate dementia with Lewy bodies and Alzheimer's disease.
    Gjerum L; Frederiksen KS; Henriksen OM; Law I; Anderberg L; Andersen BB; Bjerregaard E; Hejl AM; Høgh P; Hasselbalch SG
    J Neurol Sci; 2020 Mar; 410():116645. PubMed ID: 31911283
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differentiating Mild Cognitive Impairment, Alzheimer's Disease, and Dementia With Lewy Bodies Using Cingulate Island Sign on Perfusion IMP-SPECT.
    Kanetaka H; Shimizu S; Inagawa Y; Hirose D; Takenoshita N; Sakurai H; Hanyu H
    Front Neurol; 2020; 11():568438. PubMed ID: 33329310
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic imaging of dementia with Lewy bodies by susceptibility-weighted imaging of nigrosomes versus striatal dopamine transporter single-photon emission computed tomography: a retrospective observational study.
    Kamagata K; Nakatsuka T; Sakakibara R; Tsuyusaki Y; Takamura T; Sato K; Suzuki M; Hori M; Kumamaru KK; Inaoka T; Aoki S; Terada H
    Neuroradiology; 2017 Jan; 59(1):89-98. PubMed ID: 28035426
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differentiation of Alzheimer's disease from dementia with Lewy bodies utilizing positron emission tomography with [18F]fluorodeoxyglucose and neuropsychological testing.
    Gilman S; Koeppe RA; Little R; An H; Junck L; Giordani B; Persad C; Heumann M; Wernette K
    Exp Neurol; 2005 Feb; 191 Suppl 1():S95-S103. PubMed ID: 15629765
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of brain perfusion patterns in dementia with Lewy bodies patients with or without cingulate island sign.
    Ishibashi M; Kimura N; Sumi K; Aso Y; Matsubara E
    Geriatr Gerontol Int; 2019 Mar; 19(3):197-202. PubMed ID: 30548751
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The cingulate island sign within early Alzheimer's disease-specific hypoperfusion volumes of interest is useful for differentiating Alzheimer's disease from dementia with Lewy bodies.
    Imabayashi E; Yokoyama K; Tsukamoto T; Sone D; Sumida K; Kimura Y; Sato N; Murata M; Matsuda H
    EJNMMI Res; 2016 Dec; 6(1):67. PubMed ID: 27620458
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The 18F-FDG PET cingulate island sign and comparison to 123I-beta-CIT SPECT for diagnosis of dementia with Lewy bodies.
    Lim SM; Katsifis A; Villemagne VL; Best R; Jones G; Saling M; Bradshaw J; Merory J; Woodward M; Hopwood M; Rowe CC
    J Nucl Med; 2009 Oct; 50(10):1638-45. PubMed ID: 19759102
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparisons of clinical symptoms in biomarker-confirmed Alzheimer's disease, dementia with Lewy bodies, and frontotemporal dementia patients in a local memory clinic.
    Shea YF; Ha J; Chu LW
    Psychogeriatrics; 2015 Dec; 15(4):235-41. PubMed ID: 25533477
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnostic performance of the cingulate island sign ratio for differentiating dementia with Lewy bodies from Alzheimer's disease changes depending on the mini-mental state examination score.
    Asahara Y; Kameyama M; Ishii K; Ishibashi K
    J Neurol Sci; 2023 Dec; 455():122782. PubMed ID: 37976791
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Value of analyzing deep gray matter and occipital lobe perfusion to differentiate dementia with Lewy bodies from Alzheimer's disease.
    Shimizu S; Hanyu H; Hirao K; Sato T; Iwamoto T; Koizumi K
    Ann Nucl Med; 2008 Dec; 22(10):911-6. PubMed ID: 19142710
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.